No significant increase in Guillain-Barré syndrome after COVID-19 vaccination in adults: A vaccine adverse event reporting system study

OBJECTIVE: To investigate the association between Guillain-Barré syndrome (GBS) and COVID-19 vaccination. BACKGROUND: On July 13, 2021, the US Food and Drug Administration (FDA) released a new warning that Johnson & Johnson COVID-19 vaccine could increase the risk of developing GBS. METHODS: The...

Descripción completa

Detalles Bibliográficos
Autores principales: Jaffry, M., Mostafa, F., Mandava, K., Rosario, S., Jagarlamudi, Y., Jaffry, K., Kornitzer, J., Jedidi, K., Khan, H., Souayah, N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393181/
https://www.ncbi.nlm.nih.gov/pubmed/36055875
http://dx.doi.org/10.1016/j.vaccine.2022.08.038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393181/
https://www.ncbi.nlm.nih.gov/pubmed/36055875
http://dx.doi.org/10.1016/j.vaccine.2022.08.038

Ejemplares similares